Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays

1,25‐dihydroxyvitamin D3 [1,25(OH)2D3] exerts growth inhibitory, pro‐differentiating, and pro‐apoptotic effects on prostate cells. To better understand the molecular mechanisms underlying these actions, we employed cDNA microarrays to study 1,25(OH)2D3‐regulated gene expression in the LNCaP human prostate cancer cells.

[1]  N. Raghavachari,et al.  Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray , 2003, Breast Cancer Research and Treatment.

[2]  P. Tuohimaa,et al.  Inhibition of fatty acid synthase expression by 1α,25-dihydroxyvitamin D3 in prostate cancer cells , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  D. Peehl,et al.  Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression , 2003, Journal of cellular biochemistry.

[4]  Yiwei Li,et al.  Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. , 2002, Cancer letters.

[5]  J. Ford,et al.  p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Kubota,et al.  Liprin-α2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP , 2002 .

[7]  C. V. Van Itallie,et al.  Claudins create charge-selective channels in the paracellular pathway between epithelial cells. , 2002, American journal of physiology. Cell physiology.

[8]  Robert Tibshirani,et al.  Transcriptional programs activated by exposure of human prostate cancer cells to androgen , 2002, Genome Biology.

[9]  M. Marberger,et al.  A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  K. Pienta,et al.  The Current State of Hormonal Therapy for Prostate Cancer , 2002, CA: a cancer journal for clinicians.

[11]  J. Brooks,et al.  Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells* 210 , 2002, The Journal of Biological Chemistry.

[12]  T. Stamey,et al.  Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.

[13]  D. Beier,et al.  EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis. , 2001, American journal of physiology. Renal physiology.

[14]  I. Bièche,et al.  Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. , 2001, Carcinogenesis.

[15]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[16]  John H. White,et al.  Regulation of Gene Expression by 1α,25-Dihydroxyvitamin D3 and Its Analog EB1089 under Growth-Inhibitory Conditions in Squamous Carcinoma Cells , 2001 .

[17]  R. Vessella,et al.  Placental bone morphogenetic protein (PLAB) gene expression in normal, pre‐malignant and malignant human prostate: Relation to tumor development and progression , 2001, International journal of cancer.

[18]  C. V. Van Itallie,et al.  Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. , 2001, The Journal of clinical investigation.

[19]  P. Cohen,et al.  Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. , 2001, The Journal of urology.

[20]  A. Schulze,et al.  Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.

[21]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[22]  H. Tai,et al.  Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. , 2000, Biochemical and biophysical research communications.

[23]  D. Peehl,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Prostate Cancer Cell Growth by Androgen-Dependent and Androgen-Independent Mechanisms. , 2000, Endocrinology.

[24]  D. Feldman,et al.  1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration , 2000, Molecular and Cellular Endocrinology.

[25]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[26]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[27]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[28]  N. Weigel,et al.  Vitamin D and Prostate Cancer , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[29]  D. Trump,et al.  Vitamin D in the prevention and treatment of prostate cancer. , 1999, Seminars in urologic oncology.

[30]  T. Craig,et al.  Identification of 1α,25-Dihydroxyvitamin D3 Response Elements in the Human Transforming Growth Factor β2 Gene† , 1999 .

[31]  D. Peehl,et al.  Induction of Androgen Receptor by 1α,25-Dihydroxyvitamin D3 and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer Cells. , 1999, Endocrinology.

[32]  H. Huynh,et al.  Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins. , 1999, The Journal of endocrinology.

[33]  G. Miller.  Vitamin D and Prostate Cancer: Biologic Interactions and Clinical Potentials , 1998, Cancer and Metastasis Reviews.

[34]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[35]  L. Liotta,et al.  cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer. , 1998, Genomics.

[36]  H. Huynh,et al.  Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. , 1998, International journal of oncology.

[37]  R. Day,et al.  Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. , 1997, Urology.

[38]  R. Hromas,et al.  PLAB, a novel placental bone morphogenetic protein. , 1997, Biochimica et biophysica acta.

[39]  G. Siegal,et al.  1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  D W Nebert,et al.  The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. , 1997, Pharmacogenetics.

[41]  M. Green,et al.  Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. , 1997, Pharmacogenetics.

[42]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[43]  P. Cohen,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.

[44]  N. Weigel,et al.  1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. , 1997, Endocrinology.

[45]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.

[46]  J. Jones,et al.  Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. , 1996, Cancer research.

[47]  D. Danielpour.  Induction of transforming growth factor‐β autocrine activity by all‐trans‐retinoic acid and 1α,25‐dihydroxyvitamin D3 in NRP‐152 rat prostatic epithelial cells , 1996 .

[48]  G. Miller,et al.  Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  S. McClinton,et al.  Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors , 1994, International journal of cancer.

[50]  T. Stamey,et al.  Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. , 1994, Cancer research.

[51]  D. Peehl,et al.  Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. , 1993, Endocrinology.

[52]  P. Malloy,et al.  Vitamin DBiology, Action, and Clinical Implications , 2001 .

[53]  D. Feldman,et al.  Vitamin D: Biology, Actions, and Clinical Implications , 2001 .

[54]  D. Feldman,et al.  Editorial/Mini-Review: Vitamin D and Prostate Cancer. , 2000, Endocrinology.

[55]  T. McDonnell,et al.  Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.

[56]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[57]  P. Brown,et al.  DNA arrays for analysis of gene expression. , 1999, Methods in enzymology.

[58]  F. Pichaud,et al.  Type-I 15-hydroxyprostaglandin dehydrogenase: role in macrophage/osteoclast differentiation. , 1997, Advances in experimental medicine and biology.

[59]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.